Kamada Ltd. Ordinary Shares
KMDA
Closed
$7.12
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. The company is headquartered in Rehovot, Central(Hamerkaz) and currently employs 393 full-time employees. The company went IPO on 2005-08-01. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Key stats
Open
$7.16
Volume
31.06K
Market cap
$412.51M
Prev. close
$7.15
Impl / hst vl
-
Open interest
$0.00
$7.09
Day’s Range
$7.16
$6.92
52W Range
$9.35
Valuation
50
Valuation score
Fairly Valued
P/E
20.32
P/S
2.27
P/B
1.60
Current ratio
3.33
Debt / Equity
-
ROE
7.73%
Gross margin
42.25%
Income growth
16.00%
FCF growth
-126.38
Apr
7
Dividends
The last payment date was Apr 7, 2026
Div. per Share
$0.25
Div. Yield
3.50%
Payout Ratio
-
Div. Growth YoY
25.00%
Analysts estimates
Consensus rating
Buy
The average rating from top 5 analysts indicates that stock is expected to perform in line with the market
Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$13.26
The top 6 analysts forecasts that 12-month price may increase by 86.24%, with a low of $11.11 and a high of $15.75
$11.11
Low
$13.26
Avg
$15.75
High
Current price
Earnings
Q1 ‘26 revenue
$45.24M
Q1 ‘26 net income
$4.13M
Revenue
Net income
Previous EPS
$0.07
Estimate EPS
$0.11
Actual EPS
Estimate EPS
Explore the Healthcare sector
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply